ArticleCureus2024
A Rare Case of Solitary Fibrous Tumor Originating in the Peritoneum: Clinical and Histopathological Insights.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Robot-assisted laparoscopic resection of giant pelvic solitary fibrous tumor: a case report with literature review.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that most commonly arise from the pleura, with peritoneal origin being exceptionally uncommon. We report a case of a 51-year-old male who presented with a large abdominal mass, subsequently diagnosed as a solitary fibrous tumor originating from the peritoneum. Radiological evaluation revealed a well-defined mass with a vascular pedicle supplied by the inferior mesenteric artery, extending from the pelvis to the lower abdomen. Surgical resection of the tumor, including part of the rectosigmoid junction was performed and histopathology confirmed the diagnosis of SFT. Immunohistochemistry (IHC) demonstrated positive staining for CD34, BCL2, and STAT6, supporting the diagnosis. The patient remains disease-free after four years of follow-up. This case contributes to the limited literature on peritoneal SFTs, highlighting the importance of IHC in clinching the diagnosis and of long-term follow-up due to the potential for late recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.